Interview with Sebastiano Castorina, CEO, Takeda Italy
Takeda has more than 25 years of history in Italy and reached the 20th position in the Italian market- a striking performance in a context when it is still rare…
SIFI is the leading Italian ophthalmic company, focused on eye care since its foundation in 1935.
SIFI designs, manufactures and markets innovative pharmaceutical products, surgical and medical devices.
SIFI’s mission is to provide ophthalmologists and their patients with a wide range of therapeutic solutions to treat the most common eye diseases.
Cutting-edge innovation, continuous development, a clear understanding of patients and caregivers needs, have shaped an extensive spectrum of eye care products, developed and marketed by SIFI main Italian and foreign branches.
Headquartered in Catania (Sicily), SIFI operates directly in Italy, Romania and Mexico with a staff of more than 330 people worldwide.
Since June 2015 SIFI is backed by 21 Investimenti, private equity firm founded by Alessandro Benetton, to support the company’s international expansion and portfolio development strategy.
For more information, please visit SIFI website www.sifigroup.com.
Takeda has more than 25 years of history in Italy and reached the 20th position in the Italian market- a striking performance in a context when it is still rare…
The main distinctive point of Boehringer Ingelheim Italy within the group is its business structure, which relies on three different units: Boehringer Ingelheim Spa, Bidachem and Istituto de Angeli. Could…
Ten years of experience in the Dendrite group enabled you to cover a number of international positions, before its acquisition by Cegedim in May 2007. How has the integration progressed…
Novo Nordisk is one of the very few pharmaceutical multinationals that has such a strong focus on one therapeutic area. Although the company is now diversifying, diabetes remains its leading…
You recently declared that in a context of new emerging challenges for pharmaceutical companies, those who would survive would not be the strongest ones but the most responsive to change.…
Mr. Medda, Teva’s Italian history is relatively young, could you describe the main facts that describe Teva presence in Italy? Teva Italia was founded in 1996 and is currently the…
Italfarmaco counts amongst the few players who really sustained the growth of the Italian pharmaceutical industry in the past 10 years. Which specific values would you quote as keys to…
You created Abiogen in 1997, following the acquisition of Istituto Gentili by MSD, in order to maintain your family’s entrepreneurial tradition, keeping building on the legacy of your great-grandfather Commendatore…
Finderm is the result of a courageous entrepreneurial experience, since you initiated the operations in 1995, in the most challenging times for the Italian pharmaceutical industry. Could you briefly introduce…
Molteni was created in 1892 and progressively developed a strong manufacturing base, a very active R&D department and a growing international presence. Could you introduce the story behind such achievements?…
You declared in a recent interview that Zambon Group will always keep complying with the vision of your father Alberto, who has always refused acquisition offers from multinationals- a striking…
You are specialised in Cardiology at Padua University, in Tropical Medicine and Hygiene at London University and in Pharmacology at Modena University, in Communication at Bocconi University in Milan, and…
See our Cookie Privacy Policy Here
